The Report of the National Commission on Marihuana and Drug Abuse Acute Effects of Marihuana       (full – 1972)


radical notion                    (letter – 1974)  a?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabis&searchid=1&FIRSTINDEX=1040&res  ourcetype=HWCIT


Study Shows Long Term Marijuana Users Healthy                     (news – 1994)


Association study of a cannabinoid receptor gene (CNR1) polymorphism and schizophrenia.       (abst – 2000)                                  


 Are Cannabinoid Receptor Knockout Mice Animal Models for Schizophrenia?

(abst – 2000)    


Cannabis Use is Not Associated with the Development of Psychosis in an ‘ultra’ High-risk Group.           (abst – 2002)     


Tobacco and Cannabis Smoking Cessation Can Lead to Intoxication with Clozapine or Olanzapine.        (abst – 2002)               


Marijuana receptor gene abnormality in schizophrenia                (news – 2002)


Cannabis may treat psychiatric disorders                 (news – 2002)


Recipe For Trouble              (anecdotal/ news – 2002)


Cannabis and the brain.                   (full – 2003)


Haloperidol, but not clozapine, produces dramatic catalepsy in delta9-THC-treated rats: possible clinical implications.                                               (full – 2003)


Endocannabinoid signalling in the blood of patients with schizophrenia (full – 2003)                                        


Aetiology – Review: current evidence does not show a strong causal relation between the use of cannabis in young people and psychosocial harm                                                           (full – 2004)


Cannabis as a psychotropic medication                (letter – 2004)


Lower Negative Symptom Scores Among Cannabis-dependent Patients with Schizophrenia-spectrum Disorders: Preliminary Evidence from an African American First-episode Sample.      (abst – 2004)


How our brains fend off madness, we produce a cannabis like substance            (news – 2004)


Cannabis does not induce schizophrenia,  Dutch scientists say              (news – 2004)


On the Cannabinoid Receptor: A Study in Molecular Psychiatry             (full – 2005)



Symptoms of schizotypy precede cannabis use.                (full – 2005)


Cannabidiol as an antipsychotic. A double-blind, controlled clinical trial on cannabidiol vs. amisulpride in acute schizophrenia.                                                        (abst – 2005)


Cannabis and schizophrenia link blurs further               (news – 2005)    (may need registration)  further.html


Chemicals in Cannabis may help mentally ill                 (news – 2005)


Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug.             (full – 2006)  879X2006000400001&lng=en&nrm=iso&tlng=en


Moderation of the Effect of Adolescent-Onset Cannabis Use on Adult Psychosis by a Functional Polymorphism in the Catechol-O-Methyltransferase Gene: Longitudinal Evidence of a Gene X Environment Interaction   (full – 2006)


The Mental Health Risks of Adolescent Cannabis Use            (full – 2006)


Cannabis and psychosis              (letter – 2006)


Increased cannabinoid receptor density in the posterior cingulate cortex in schizophrenia. (abst – 2006)                            


An Experimental Study of Catechol-O-Methyltransferase Val(158)Met Moderation of Delta-9-Tetrahydrocannabinol-Induced Effects on Psychosis and Cognition.

(abst – 2006)  techol_O_Methyltransferase_Val_158_Met_Moderation_of_Delta_9_Tetrahydrocannabinol_Induced_Effe  cts_on_Psychosis_and_Cognition


Cannabis use does not cause schizophrenia                (news – 2006)


No Increased Schizophrenia Risk With Use Of Cannabis              (news – 2006) abis


Cannabis is a First-Line Treatment for Childhood Mental Disorders

(news – 2006)       childhood-mental-disorders/


Reefer Madness Refuted             (letter – 2007)


A Comparison of Symptoms and Family History in Schizophrenia with and Without Prior Cannabis Use: Implications for the Concept of Cannabis Psychosis.

(abst – 2007)


Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: Impact of cannabis use.                                        (abst – 2007) spinal_fluid_of_first_episode_schizophrenic_patients:_Impact_of_cannabis_use


Cannabinoids and psychosis.               (abst – 2007)  5&ordinalpos=185&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum


Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis (full – 2008)  nnabinoid&searchid=1&FIRSTINDEX=1200&resourcetype=HWCIT


The effects of cannabis abuse on the symptoms of schizophrenia: patient perspectives. (abst – 2008)                           


Maternal tobacco, cannabis and alcohol use during pregnancy and risk of adolescent psychotic symptoms in offspring.                                                       (full – 2009)


Cannabis and suicide: longitudinal study.               (full – 2009)


Parasitic brain infection, endocannabinoids, and schizophrenia.               (abst – 2009)  annabinoids_and_schizophrenia_


The role of cannabis in cognitive functioning of patients with schizophrenia. (abst – 2009) tive_functioning_of_patients_with_schizophrenia_


Cannabis use and deliberate self-harm in adolescence: a comparative analysis of associations in England and Norway.                                                                   (abst – 2009) elf_harm_in_adolescence:_a_comparative_analysis_of_associations_in_England_and_Norway_


Opposite relationships between cannabis use and neurocognitive functioning in bipolar disorder and schizophrenia.                                                           (abst – 2009)  ween_cannabis_use_and_neurocognitive_functioning_in_bipolar_disorder_and_schizophrenia_


Effects of cannabidiol on amphetamine-induced oxidative stress generation in an animal model of mania                                         (abst – 2009)  annabinoid&searchid=1&FIRSTINDEX=320&sortspec=date&resourcetype=HWCIT


Synthetic delta-9-tetrahydrocannabinol (dronabinol) can improve the symptoms of schizophrenia.           (abst – 2009)  nnabinol__dronabinol__can_improve_the_symptoms_of_schizophrenia_


Can recreational doses of THC produce significant dopamine release in the human striatum?        (abst – 2009)



Assessing the impact of cannabis use on trends in diagnosed schizophrenia in the United Kingdom from 1996 to 2005.                                                    (abst – 2009)


If cannabis caused schizophrenia-how many cannabis users may need to be prevented in order to prevent one case of schizophrenia? England and Wales calculations.

(abst – 2009)   phrenia_how_many_cannabis_users_may_need_to_be_prevented_in_order_to_prevent_one_case_of_schiz  ophrenia_England_and_Wales_calculations_


Minimal Relationship Between Cannabis And Schizophrenia Or Psychosis, Suggested By New Study    (news – 2009)             


Schizophrenia link to cannabis denied               (news – 2009)  detail/article.html


Cannabis and smoking gene links to schizophrenia ‘unfounded’               (news – 2009)


New study suggests minimal relationship between cannabis and schizophrenia or psychosis          (news – 2009)                    


Science: The development of the number of new schizophrenia cases in the UK does not support the hypothesis that cannabis use increases schizophrenia risk                                                               (news – 2009)


THC can improve symptoms of schizophrenia                (news – 2009)


Maternal Marijuana use not Associated with Psychotic Symptoms , but Alcohol is. (news – 2009)  associated-with-psychotic-symptoms-but-alcohol-is&catid=3:newsflash


Do patients think cannabis causes schizophrenia? – A qualitative study on the causal beliefs of cannabis using patients with schizophrenia                                                        (full – 2010)


Reasons for illicit drug use in people with schizophrenia: Qualitative study (full – 2010)                         


Are cannabis use disorders associated with an earlier age at onset of psychosis? A study in first episode schizophrenia.                                           (full – 2010)


Therapeutical use of the cannabinoids in psychiatry                (full – 2010)  44462010000500009&lng=en&nrm=iso&tlng=en


A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in Schizophrenia.                                                    (full – 2010)


Cannabinoid–Dopamine Interaction in the Pathophysiology and Treatment of CNS Disorders      (full – 2010)                  


Endocannabinoids and Schizophrenia                 (link to PDF– 2010)


Tardive Dystonia and the Use of Cannabis                (letter – 2010)


A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice.                                                             (abst – 2010) acute_and_chronic_Delta9_tetrahydrocannabinol_and_cannabidiol_in_C57BL/6JArc_mice_


Cannabinoid self-administration attenuates PCP-induced schizophrenia-like symptoms in adult rats.       (abst – 2010)           


Brain cannabinoid CB2 receptor in schizophrenia.              (abst – 2010)


Does intravenous {triangleup}9-tetrahydrocannabinol increase dopamine release? A SPET study.           (abst – 2010)              


The Impact of Cannabis Use on Cognitive Functioning in Patients With Schizophrenia: A Meta-analysis of Existing Findings and New Data in a First-Episode Sample.

(abst – 2010)          


Attraction to cannabis among men with schizophrenia: a phenomenological study.

(abst – 2010)       


Oral THC Reduces Aggressive Behavior In Patients With Refractory Psychosis, Study Says        (news – 2010)                


Risk of suicide spurs rimonabant trial to end.                (news – 2010)


Deletion of CB2 Cannabinoid Receptor Induces Schizophrenia-Related Behaviors in Mice          (full – 2011)              


Cannabis use predicts shorter duration of untreated psychosis and lower levels of negative symptoms in first-episode psychosis: a South African study.                                                            (full – 2011)


Cannabinoids for the Treatment of Schizophrenia? A Balanced Neurochemical Framework for Both Adverse and Therapeutic Effects of Cannabis Use                                                                     (full – 2011)


Gadolinium-HU-308-incorporated micelles.                (full – 2011)


Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full – 2011)                          


Cannabis, COMT and psychotic experiences.              (full – 2011)


Synthetic cannabinoid JWH-018 and psychosis: An explorative study.               (abst – 2011) 18_and_psychosis:_An_explorative_study_


Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions. (abst – 2011)                              


Psychopharmacological comparison of schizophrenia spectrum disorder with and without cannabis dependency.                                                  (abst – 2011)


Endocannabinoid system dysfunction in mood and related disorders.           (abst – 2011)


Cannabis with high cannabidiol content is associated with fewer psychotic experiences. (abst – 2011)                           


Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being.                                                                                   (abst – 2011)


The Dopamine and Cannabinoid Interaction in the Modulation of Emotions and Cognition: Assessing the Role of Cannabinoid CB1 Receptor in Neurons Expressing Dopamine D1 Receptors.        (abst – 2011)                                             


History of cannabis use is not associated with alterations in striatal dopamine D2/D3 receptor availability.                                                (abst – 2011)


Popular intoxicants: what lessons can be learned from the last 40 years of alcohol and cannabis regulation?                                               (abst – 2011)


The schizophrenia susceptibility gene neuregulin 1 modulates tolerance to the effects of cannabinoids.    (abst – 2011) y_gene_neuregulin_1_modulates_tolerance_to_the_effects_of_cannabinoids_


Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects.                                                        (abst – 2011) psychiatry:_in_search_of_a_neurobiological_basis_for_detrimental_and_potential_therapeutic_effects_


The endocannabinoid system in the regulation of emotions throughout lifespan: a discussion on therapeutic perspectives.                                                        (abst – 2011) n_the_regulation_of_emotions_throughout_lifespan:_a_discussion_on_therapeutic_perspectives_


Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia.                                                  (abst – 2011)


Association between a cannabinoid receptor gene (CNR1) polymorphism and cannabinoid-induced alterations of the auditory event-related P300 potential. (abst – 2011)




Deletion of CB2 cannabinoid receptor induces schizophrenia-related behaviors in mice. (abst – 2011)                           


Marijuana Use Associated With ‘Superior’ Cognitive Performance In Schizophrenic Patients, Study Says                                                (news – 2011)


A Brain Wrought Without Omega-3                (news – 2011)


Debunking the Myth of a Link Between Marijuana and Mental Illness             (news – 2011)


COMT; another “wrong” result for the reefer madness hype.               (news – 2011)


The Link Between Marijuana and Schizophrenia                (news – 2011),8599,2005559,00.html


Why Omega-3s Affect Your Mood                (news – 2011)


Acute mental disturbance caused by synthetic cannabinoid: a potential emerging substance of abuse in Hong Kong.                                                                       (full – 2012)


Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia.           (full – 2012)


Plasma Endocannabinoid Alterations in Individuals with Substance Use Disorder are Dependent on the “Mirror Effect” of Schizophrenia.                                                            (full – 2012)


A polymorphism in the gene of the endocannabinoid-degrading enzyme FAAH (FAAH C385A) is associated with emotional–motivational reactivity                                                           (full – 2012)


The dynamic nature of type 1 cannabinoid receptor (CB1) gene transcription (full – 2012)                            


Medical use of cannabis. Cannabidiol: A new light for schizophrenia?               (full – 2012)


Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders.                                                     (abst  – 2012)


Cannabinoid modulation of noradrenergic circuits: Implications for psychiatric disorders. (abst – 2012)                          


Cortical basket cell dysfunction in schizophrenia.              (abst – 2012)


Increased gray matter density in patients with schizophrenia and cannabis use: A voxel- based morphometric study using DARTEL.                                                          (abst – 2012)


Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?                                              (abst – 2012)


A current overview of cannabinoids and glucocorticoids in facilitating extinction of aversive memories: Potential extinction enhancers.                                                              (abst – 2012)


Antipsychotic Profile of Cannabidiol and Rimonabant in an Animal Model of Emotional Context Processing in Schizophrenia.                                                   (abst – 2012)


A critical review of the antipsychotic effects of Cannabidiol: 30 years of a translational investigation.     (abst – 2012)                   


Neurocognitive functioning and cannabis use in schizophrenia.               (abst – 2012)


Subjective and Physiological Effects of Oromucosal Sprays Containing Cannabinoids (Nabiximols): Potentials and Limitations for Psychosis Research.                                                             (abst – 2012)


Alcohol and cannabis use and mortality in people with schizophrenia and related psychotic disorders.     (abst – 2012)                           


Nutritional n-3 polyunsaturated fatty acids deficiency alters cannabinoid receptor signaling pathway in the brain and associated anxiety-like behavior in mice. (abst – 2012)


Chronic cannabinoid exposure reduces phencyclidine-induced schizophrenia-like positive symptoms in adult rats.                                                    (abst – 2012)


Investigation of endocannabinoid system genes suggests association between peroxisome proliferator activator receptor-α gene (PPARA) and schizophrenia.                                                 (abst – 2012)


Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment.                                              (abst – 2012)


Chronic cannabinoid exposure reduces phencyclidine-induced schizophrenia-like positive symptoms in adult                                            (abst – 2012)[]=citjournalarticl e_374483_1


Binding of a tritiated inverse agonist to cannabinoid CB1 receptors is increased in patients with schizophrenia                                                          (abst – 2012)


Study: Marijuana Linked to Lower Mortality Rate for Patients with Psychotic Disorders (news – 2012)  with_psychotic_disorders


Marijuana Compound Treats Schizophrenia with Few Side Effects: Clinical Trial (news – 2012)                                      


Creativity in cannabis-users and in drug addicts in maintenance treatment and in rehabilitation.    (abst – 2013)                                    


Cannabis and psychosis: what causes what?                     (abst – 2013)


Stronger evidence is needed before accepting that cannabis plays an important role in the aetiology of schizophrenia in the population.                                                                     (abst – 2013)


Chronic cannabinoid exposure reduces phencyclidine-induced schizophrenia-like positive symptoms in adult rats                                                             (abst – 2013)


Neonatal lipopolysaccharide treatment has long term effects on monoaminergic and cannabinoid receptors in the rat.                                                                         (abst – 2013)

Share a link for